ViMREX GmbH
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Clinical Trial With Local Decitabine Treatment of HPV-Induced VIN Grade 2/3 (DelVIN) (NCT05717621) | ViMREX GmbH | 2023-03-28 |
Track ViMREX GmbH automatically
Every clearance here is in the API, with alerts when new ones post.